Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2003

Dec 31, 2003

29777_dirs_2003-12-31_5607d2be-8bd3-46fd-b065-06ce0ac43ad6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2003-12-31

Reporting Person: WYATT LANCE B (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2003-12-31 Common shares without par value M 30000 $37.00 Acquired 172960 Direct
2003-12-31 Common shares without par value F 26048 $46.57 Disposed 146912 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2003-12-31 Option (right to buy) $37.00 M 30000 Disposed 2008-02-12 common shares (30000) Direct
2003-12-31 Option (right to buy) $46.57 A 26048 Acquired 2008-02-12 common shares (26048) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 22461 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 29, 2003.

F2: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.